Compare

CVS/$CVS

1D1W1M3M6MYTD1Y5YMAX

About CVS

CVS Health currently offers a diverse set of healthcare services, although it plans to split into two organizations in early 2028. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix.
Ticker
$CVS
Sector
Health
Primary listing
NYSE
Employees
259,500

CVS Metrics

BasicAdvanced
$110B
10.00
$8.58
0.58
$2.66
3.10%

What the Analysts think about CVS

Analyst ratings (Buy, Hold, Sell) for CVS stock.
Analyst projections of the future price of CVS stock.

Bulls say / Bears say

Third-quarter revenue rose 5.4% and adjusted EPS increased to $2.09 from $1.60 a year earlier. CVS lifted its 2026 adjusted EPS floor to $8.20 and cash-flow forecast to at least $15.5 billion, signalling stronger near-term earnings and cash generation. (CVS Health)
Aetna’s medical benefit ratio improved to 91.3% from 92.8% a year earlier, while adjusted operating income in Health Care Benefits rose. CVS raised that segment’s 2026 outlook, supporting the case that its insurance margin recovery is progressing. (CVS Health)
CVS plans to separate its insurance, PBM and care businesses from its retail pharmacy operations by the first half of 2028. The two-company structure could give each business clearer strategic focus and accountability. (CVS Health)
The FTC settlement requires Caremark to change parts of its commercial offering, including passing rebates through to members, delinking some fees from drug list prices and changing pharmacy reimbursement. These rules could pressure PBM economics, even as they resolve the FTC’s case. (Federal Trade Commission)
CVS warned that medical cost trends remain elevated and that macroeconomic headwinds could weigh on results. That leaves uncertainty around how durable Aetna’s improving margins will be. (CVS Health)
Retail pharmacy revenue fell 2% in the third quarter, with CVS citing drug price reductions, new generic medicines and reimbursement pressure. Those headwinds could limit growth even though prescription volumes increased. (CVS Health)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.

CVS Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

CVS Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.